Marc Stapley - 02 Jun 2026 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Jun 2026, 21:38:26 UTC
Prior SEC filing
23 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Wygant, as attorney-in-fact

Key filing fact

Marc Stapley filed Form 4 for VERACYTE, INC. (VCYT) on 04 Jun 2026.

Key facts

  • This page summarizes Marc Stapley's Form 4 filing for VERACYTE, INC. (VCYT).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Jun 2026, 21:38.

Change

  • Previous filing in this sequence was filed on 23 Jun 2026.
  • Current net transaction value: -$6,919,585.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001539796 Primary reporting owner

Stapley Marc

Relationship
Chief Executive Officer, Director
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Tax liability

Transaction value
Shares
-9,012
Change %
-2%
Price
$47.80*
Shares after
440,494
Date
02 Jun 2026
Ownership
Direct
Footnotes
F1, F2
VCYT transaction

Common Stock

Options Exercise

Transaction value
Shares
+138,051
Change %
+31%
Price
$36.60*
Shares after
578,545
Date
04 Jun 2026
Ownership
Direct
Footnotes
F3
VCYT transaction

Common Stock

Sale

Transaction value
$6,919,585
Shares
-138,051
Change %
-24%
Price
$50.12
Shares after
440,494
Date
04 Jun 2026
Ownership
Direct
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-138,051
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
138,051
Exercise price
$36.60
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

Footnote F2

Due to an administrative error, shares of common stock acquired by the Reporting Person under the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2025 were incorrectly reported as 529 shares of common stock instead of 382 shares of common stock in a Form 4 filed on September 4, 2025, and these shares were overreported in subsequent Forms 4 filed by the Reporting Person. This column reflects the corrected balance.

Footnote F3

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025.

Footnote F4

Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F5

The option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .